Sun Pharmaceutical has signed an agreement with RPG life science to divest seven prescription brands in India, owned by Sun Pharmaceutical Industries and its subsidiary, for a consideration of Rs 41 crore. This divestment is subject to receipt of Competition Commission of India’s (CCI) approval.
The seven divested brands include brands used for treatment of respiratory-track infections, urological disorders, cardiovascular diseases and brands in health supplements segment.
Sun Pharma is the world's fifth largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business, economies of scale and an extremely skilled team enable us to deliver quality products in a timely manner at affordable prices.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1873.25 |
| Dr. Reddys Lab | 1294.10 |
| Cipla | 1321.45 |
| Zydus Lifesciences | 948.00 |
| Lupin | 2277.95 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: